NewsBenzingaSignalé samedi, Incyte cofinancera l’étude de phase 1/2 de Genmab sur la combinaison de petosemtamab dans le cancer colorectal métastatique de première ligne muté KRAS G12D, et fournira l’approvisionnement clinique en INCB161734 Signalé samedi, Incyte cofinancera l’étude de phase 1/2 de Genmab sur la combinaison de petosemtamab dans le cancer colorectal métastatique de première ligne muté KRAS G12D, et fournira l’approvisionnement clinique en INCB161734 Benzinga 2026.10.26 07:07 (GMT+0) Open on Benzinga Other news Honeywell Technologies Debuts Forge Plant Cognition At Dangote’s Lekki Refinery, Estimating More Than 29 Cents A Barrel In Operational Benefit, Or Over $60M Per Year At Full Capacity Trader Mk4's NEAR long shows $12.15M unrealized profit, long position worth over $25M Baron Health Care Fund Q3 2026 Top Contributors And Detractors Sturm, Ruger: Strategic Alliance With Beretta Supports Long-Term Growth (NYSE:RGR) Robert Reich Says Elon Musk’s SpaceX and Starlink Should Become Publicly Owned, Musk Fires Back: ‘Stealing Companies Is a Serious Crime' Bristol Myers Squibb, SystImmune’s Iza-Bren Hits Primary Endpoint In Phase 3 PANKU-Lung01 Interim Analysis, Median PFS 11.1 Versus 5.7 Months (HR 0.40) Over Platinum Chemotherapy In EGFR-Mutated NSCLC
Honeywell Technologies Debuts Forge Plant Cognition At Dangote’s Lekki Refinery, Estimating More Than 29 Cents A Barrel In Operational Benefit, Or Over $60M Per Year At Full Capacity
Robert Reich Says Elon Musk’s SpaceX and Starlink Should Become Publicly Owned, Musk Fires Back: ‘Stealing Companies Is a Serious Crime'
Bristol Myers Squibb, SystImmune’s Iza-Bren Hits Primary Endpoint In Phase 3 PANKU-Lung01 Interim Analysis, Median PFS 11.1 Versus 5.7 Months (HR 0.40) Over Platinum Chemotherapy In EGFR-Mutated NSCLC
